Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium.
Tohi Y, Kato T, Kobayashi K, Daizumoto K, Fukuhara H, Ohira S, Katayama S, Shimizu R, Takamoto A, Nishimura K, Ikeda K, Nagami T, Hayashida Y, Hirama H, Naito H, Tomida R, Sasaki Y, Yamamoto S, Shimizu S, Sugimoto M; Chu-shikoku Japan Urological Consortium. Tohi Y, et al. Among authors: daizumoto k. Jpn J Clin Oncol. 2024 Feb 7;54(2):167-174. doi: 10.1093/jjco/hyad143. Jpn J Clin Oncol. 2024. PMID: 37840362
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium.
Tohi Y, Kato T, Fukuhara H, Kobayashi K, Ohira S, Ikeda K, Daizumoto K, Katayama S, Shimizu R, Nishimura K, Nagami T, Hayashida Y, Hirama H, Takamoto A, Dainichi T, Sugimoto M; Chu-shikoku Japan Urological Consortium. Tohi Y, et al. Among authors: daizumoto k. Int J Clin Oncol. 2022 Aug;27(8):1348-1355. doi: 10.1007/s10147-022-02183-z. Epub 2022 May 20. Int J Clin Oncol. 2022. PMID: 35596089
[A Case of Pappilary Renal Cell Caircinoma which Responded Well to the Combination Therapy of Ipilimumab and Nivolumab --A CASE REPORT-].
Fukatani Y, Daizumoto K, Kadoriku F, Yamamoto H, Sasaki Y, Ozaki K, Ueno Y, Tuda M, Kusuhara Y, Fukawa T, Yamamoto Y, Yamaguchi K, Takahashi M, Kanayama H, Niki M, Uehara H. Fukatani Y, et al. Among authors: daizumoto k. Hinyokika Kiyo. 2022 Apr;68(4):107-111. doi: 10.14989/ActaUrolJap_68_4_107. Hinyokika Kiyo. 2022. PMID: 35613898 Free article. Japanese.
Appropriate management reduces radiation exposure in daily urological practice.
Ozaki K, Fukawa T, Kawanaka T, Daizumoto K, Sasaki Y, Ueno Y, Tsuda M, Kusuhara Y, Yamamoto Y, Yamaguchi K, Takahashi M, Kanayama HO. Ozaki K, et al. Among authors: daizumoto k. Int J Urol. 2022 Oct;29(10):1207-1212. doi: 10.1111/iju.14971. Epub 2022 Jul 18. Int J Urol. 2022. PMID: 35851694
Clinical application of virtual imaging guided Robot-assisted partial nephrectomy.
Shiozaki K, Kawanishi Y, Sasaki Y, Daizumoto K, Tsuda M, Izumi K, Kusuhara Y, Fukawa T, Yamamoto Y, Yamaguchi K, Takahashi M, Kanayama H. Shiozaki K, et al. Among authors: daizumoto k. J Med Invest. 2022;69(3.4):237-243. doi: 10.2152/jmi.69.237. J Med Invest. 2022. PMID: 36244775 Free article.
A propensity score matching study on robot-assisted radical cystectomy for older patients: comparison of intracorporeal ileal conduit and cutaneous ureterostomy.
Kadoriku F, Sasaki Y, Fukuta K, Atagi Y, Shiozaki K, Daizumoto K, Tomida R, Ueno Y, Tsuda M, Kusuhara Y, Fukawa T, Yanagihara Y, Yamaguchi K, Yamamoto Y, Izaki H, Takahashi M, Yamashi S, Kan M, Kanayama H. Kadoriku F, et al. Among authors: daizumoto k. BMC Urol. 2022 Nov 7;22(1):174. doi: 10.1186/s12894-022-01123-3. BMC Urol. 2022. PMID: 36344965 Free PMC article.
42 results